PURPOSE: The purpose of this study was to evaluate the possible use of changes in apparent diffusion coefficient (ADC) measured by magnetic resonance imaging for pretreatment prediction and early detection of tumor response in a mouse model during fractionated chemoradiotherapy. MATERIALS AND METHODS: Athymic mice with bilateral HT29 xenografts on rear flanks were allocated into three groups: control, capecitabine, and capecitabine and oxaliplatin. The left flanks of the mice received daily irradiation. T2 and diffusion images were acquired before therapy and weekly for the following 9 weeks. Pretreatment and changes in ADC were calculated and compared with tumor doubling growth delay. RESULTS: No correlations between pretreatment ADC and changes in tumor volumes after therapy were seen. All treated tumors, except those receiving capecitabine (P = .06), showed increased mean tumor ADC values 11 days after initialization of therapy (P < .05) before returning to pretreatment values within 5 days posttherapy (day 18 after onset of therapy). This increase in mean tumor ADC showed a strong positive correlation (r = 0.92, P < .01) with mean tumor doubling growth delay. CONCLUSIONS: Pretreatment ADC values did not predict the effectiveness of therapy, whereas early changes in mean ADC quantitatively correlated with treatment outcome.
PURPOSE: The purpose of this study was to evaluate the possible use of changes in apparent diffusion coefficient (ADC) measured by magnetic resonance imaging for pretreatment prediction and early detection of tumor response in a mouse model during fractionated chemoradiotherapy. MATERIALS AND METHODS: Athymic mice with bilateral HT29 xenografts on rear flanks were allocated into three groups: control, capecitabine, and capecitabine and oxaliplatin. The left flanks of the mice received daily irradiation. T2 and diffusion images were acquired before therapy and weekly for the following 9 weeks. Pretreatment and changes in ADC were calculated and compared with tumor doubling growth delay. RESULTS: No correlations between pretreatment ADC and changes in tumor volumes after therapy were seen. All treated tumors, except those receiving capecitabine (P = .06), showed increased mean tumor ADC values 11 days after initialization of therapy (P < .05) before returning to pretreatment values within 5 days posttherapy (day 18 after onset of therapy). This increase in mean tumor ADC showed a strong positive correlation (r = 0.92, P < .01) with mean tumor doubling growth delay. CONCLUSIONS: Pretreatment ADC values did not predict the effectiveness of therapy, whereas early changes in mean ADC quantitatively correlated with treatment outcome.
Authors: E Kapiteijn; C A Marijnen; I D Nagtegaal; H Putter; W H Steup; T Wiggers; H J Rutten; L Pahlman; B Glimelius; J H van Krieken; J W Leer; C J van de Velde Journal: N Engl J Med Date: 2001-08-30 Impact factor: 91.245
Authors: R J Gillies; Z M Bhujwalla; J Evelhoch; M Garwood; M Neeman; S P Robinson; C H Sotak; B Van Der Sanden Journal: Neoplasia Date: 2000 Jan-Apr Impact factor: 5.715
Authors: J L Evelhoch; R J Gillies; G S Karczmar; J A Koutcher; R J Maxwell; O Nalcioglu; N Raghunand; S M Ronen; B D Ross; H M Swartz Journal: Neoplasia Date: 2000 Jan-Apr Impact factor: 5.715
Authors: Marwan G Fakih; Ashwani Rajput; Gary Y Yang; Lakshmi Pendyala; Karoly Toth; Judy L Smith; David D Lawrence; Youcef M Rustum Journal: Int J Radiat Oncol Biol Phys Date: 2006-06-05 Impact factor: 7.038
Authors: T L Chenevert; L D Stegman; J M Taylor; P L Robertson; H S Greenberg; A Rehemtulla; B D Ross Journal: J Natl Cancer Inst Date: 2000-12-20 Impact factor: 13.506
Authors: Daniel C Colvin; Mary E Loveless; Mark D Does; Zou Yue; Thomas E Yankeelov; John C Gore Journal: Magn Reson Imaging Date: 2010-12-28 Impact factor: 2.546
Authors: Benjamin A Hoff; Thomas L Chenevert; Mahaveer S Bhojani; Thomas C Kwee; Alnawaz Rehemtulla; Denis Le Bihan; Brian D Ross; Craig J Galbán Journal: Magn Reson Med Date: 2010-09-21 Impact factor: 4.668
Authors: Lori R Arlinghaus; Xia Li; A Ridwan Rahman; E Brian Welch; Lei Xu; John C Gore; Thomas E Yankeelov Journal: Magn Reson Imaging Date: 2011-04-29 Impact factor: 2.546
Authors: Craig J Galbán; Suresh K Mukherji; Thomas L Chenevert; Charles R Meyer; Daniel A Hamstra; Peyton H Bland; Timothy D Johnson; Bradford A Moffat; Alnawaz Rehemtulla; Avraham Eisbruch; Brian D Ross Journal: Transl Oncol Date: 2009-08-18 Impact factor: 4.243